Drug Profile
Dornase alfa biosimilar - International Biotech Center Generium
Alternative Names: Dornase alfa biosimilar - GENERIUM Pharmaceuticals; GNR-039; Tigerase; TigerazeLatest Information Update: 07 Jun 2023
Price :
$50
*
At a glance
- Originator International Biotech Center Generium
- Developer GENERIUM Pharmaceuticals
- Class Antifibrotics; Enzymes; Eye disorder therapies; Recombinant proteins
- Mechanism of Action Deoxyribonuclease 1 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cystic fibrosis
- No development reported COVID 2019 infections